Inventor
Hans-Michael Wolff
Inventor
Monheim, DE
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61LMethods or apparatus for sterilising materials or objects in general7%
C07DHeterocyclic compounds7%
C07CAcyclic or carbocyclic compounds5%
A61FFilters implantable into blood vessels3%
A61NElectrotherapy3%
PatentTitleYear
10,350,174Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine201910,130,589Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine20189,925,150'Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine'20189,186,335'Hot melt TTS for administering rotigotine'20159,034,914'Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis'20158,754,120'Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis'20148,617,591'Transdermal delivery system for the administration of rotigotine'20138,592,477'Polymorphic form of rotigotine and process for production'20138,246,980'Transdermal delivery system'20128,246,979'Transdermal delivery system for the administration of rotigotine'20128,232,414'Polymorphic form of rotigotine and process for production'20128,211,462'Hot-melt TTS for administering rotigotine'20127,989,654'High purity bases of 3,3-diphenylpropylamino monoesters'20117,919,117'Transdermal delivery of (R)-3,3-diphenylpropylamin-monoestern'20117,670,621'Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters'20107,632,859'Iontophoretic delivery of rotigotine for the treatment of Parkinson\'s disease'20096,783,769'Transdermal therapeutic system TTS containing tolterodine'20046,562,367'Transdermal therapeutic system (TTS) for administering sexual steroid hormones'20036,555,131'Therapeutical system for transdermal delivery of levonorgestrel'20036,555,129'Transdermal therapeutic system (TTS) containing oxybutynin'20036,461,636'Transdermal therapeutic system containing pergolide'20025,817,697'Transdermal presentation of nitroglycerin for preventing undesired labor'19985,603,948'Active ingredient patch for low-melting and/or volatile active ingredients'19975,527,536'Active ingredient patch for low-melting and/or volatile active ingredients'19965,498,418'Nitroglycerine plaster and process for its production'19965,393,529'Estrogen-containing active substance plaster'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2010Patents assigned to SANOL ARZNEI SCHWARZ GMBH (12)· patent assignee history
1995–2019Based in Monheim, DE· patent location history
2011–2019Patents assigned to UCB PHARMA GMBH (14)· patent assignee history
2012–2015Patents assigned to WOLFF HANS-MICHAEL (8)· patent assignee history
2012–2013Patents assigned to HANNAY MIKE (3)· patent assignee history
2018–2019Patents assigned to LTS LOHMANN THERAPIE SYSTEME AG (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB PHARMA GMBH | 14 | 2011–2019 |
| SANOL ARZNEI SCHWARZ GMBH | 12 | 1995–2010 |
| WOLFF HANS-MICHAELself | 8 | 2012–2015 |
| HANNAY MIKE | 3 | 2012–2013 |
| LTS LOHMANN THERAPIE SYSTEME AG | 3 | 2018–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Monheim, DE | 26 | 1995–2019 |